微創医療科学に関するコメント

$微創医療科学(00853.HK)$ does anyone know why the coy keeps spinning off its business unit but doesn't seem to be attributing any value to existing shareholders? isn't it like siphoning off value from existing shareholders?

$微創医療科学(00853.HK)$
The launch of robots has not boosted the market value of minimally invasive medicine at all. Very disappointed. This was out of the blue. The medical and instrument sector has been cold recently. There was no interest from listed institutional investors. Equity issues are rare. The offering is worth just over $25 billion in Series C financing. Reflect on this increase did not achieve the desired purpose.

$微創医療科学(00853.HK)$
Minimally Invasive has acquired Hemovent inc., a 2013 Aachen based medical device company specializing in innovative in vitro life support systems, for an aggregate price of up to €123 million. The company's main product is ECMO, and its MOBYBOX System, which is the world's first ECMO System integrating blood pump and membrane lung, has received CE certification.

$微創医療科学(00853.HK)$ The market is very large and has many subdivisions. Because it is constantly iterating and has obvious first-mover advantages, even the giants can only consolidate their position through acquisition. With minimally invasive research and development capabilities and layout capabilities, plus the financial support of well-known institutions, minimally invasive will surely become a giant in the future.